Connection

Mark Kindy to Animals

This is a "connection" page, showing publications Mark Kindy has written about Animals.
Connection Strength

1.766
  1. Plant-Based Nutritional Supplementation Attenuates LPS-Induced Low-Grade Systemic Activation. Int J Mol Sci. 2021 Jan 08; 22(2).
    View in: PubMed
    Score: 0.054
  2. Effects of GrandFusion Diet on Cognitive Impairment in Transgenic Mouse Model of Alzheimer's Disease. Nutrients. 2020 Dec 30; 13(1).
    View in: PubMed
    Score: 0.054
  3. Serum Amyloid A-Mediated Inflammasome Activation of Microglial Cells in Cerebral Ischemia. J Neurosci. 2019 11 20; 39(47):9465-9476.
    View in: PubMed
    Score: 0.049
  4. GM6 Attenuates Alzheimer's Disease Pathology in APP Mice. Mol Neurobiol. 2019 Sep; 56(9):6386-6396.
    View in: PubMed
    Score: 0.047
  5. Reduced Neuroinflammation and Improved Functional Recovery after Traumatic Brain Injury by Prophylactic Diet Supplementation in Mice. Nutrients. 2019 01 31; 11(2).
    View in: PubMed
    Score: 0.047
  6. Impact of nutrition on inflammation, tauopathy, and behavioral outcomes from chronic traumatic encephalopathy. J Neuroinflammation. 2018 Sep 24; 15(1):277.
    View in: PubMed
    Score: 0.046
  7. The Effect of Diet on Improved Endurance in Male C57BL/6 Mice. Nutrients. 2018 Aug 16; 10(8).
    View in: PubMed
    Score: 0.046
  8. Daily supplementation with GrandFusion? improves memory and learning in aged rats. Aging (Albany NY). 2017 03 24; 9(3):1041-1054.
    View in: PubMed
    Score: 0.041
  9. High-Sodium Diet Has Opposing Effects on?Mean Arterial Blood Pressure and?Cerebral Perfusion in a Transgenic Mouse Model of Alzheimer's Disease. J Alzheimers Dis. 2016 10 04; 54(3):1061-1072.
    View in: PubMed
    Score: 0.040
  10. A therapeutic cancer vaccine against GL261 murine glioma. J Transl Med. 2016 Jan 05; 14:1.
    View in: PubMed
    Score: 0.038
  11. Dietary supplementation of GrandFusion(?) mitigates cerebral ischemia-induced neuronal damage and attenuates inflammation. Nutr Neurosci. 2016 Sep; 19(7):290-300.
    View in: PubMed
    Score: 0.036
  12. The cysteine protease cathepsin B is a key drug target and cysteine protease inhibitors are potential therapeutics for traumatic brain injury. J Neurotrauma. 2014 Mar 01; 31(5):515-29.
    View in: PubMed
    Score: 0.033
  13. A contusion model of severe spinal cord injury in rats. J Vis Exp. 2013 Aug 17; (78).
    View in: PubMed
    Score: 0.032
  14. Nanoparticles for targeted delivery of antioxidant enzymes to the brain after cerebral ischemia and reperfusion injury. J Cereb Blood Flow Metab. 2013 Apr; 33(4):583-92.
    View in: PubMed
    Score: 0.031
  15. Protective effects of incensole acetate on cerebral ischemic injury. Brain Res. 2012 Mar 14; 1443:89-97.
    View in: PubMed
    Score: 0.029
  16. Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing A?PP containing the wild-type ?-secretase site sequence. J Alzheimers Dis. 2012; 29(4):827-40.
    View in: PubMed
    Score: 0.029
  17. Transcranial laser therapy attenuates amyloid-? peptide neuropathology in amyloid-? protein precursor transgenic mice. J Alzheimers Dis. 2011; 23(3):521-35.
    View in: PubMed
    Score: 0.027
  18. Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of A?PP transgenic mice. J Alzheimers Dis. 2011; 25(2):295-307.
    View in: PubMed
    Score: 0.027
  19. The cysteine protease inhibitor, E64d, reduces brain amyloid-? and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, ?-secretase activity. J Alzheimers Dis. 2011; 26(2):387-408.
    View in: PubMed
    Score: 0.027
  20. Pharmacogenetic features of cathepsin B inhibitors that improve memory deficit and reduce beta-amyloid related to Alzheimer's disease. Biol Chem. 2010 Aug; 391(8):861-72.
    View in: PubMed
    Score: 0.026
  21. The impact of methylmercury on 1,25-dihydroxyvitamin D3-induced transcriptomic responses in dolphin skin cells. Biol Chem. 2010 Feb-Mar; 391(2-3):245-258.
    View in: PubMed
    Score: 0.025
  22. Magnesium chloride in a polyethylene glycol formulation as a neuroprotective therapy for acute spinal cord injury: preclinical refinement and optimization. J Neurotrauma. 2009 Aug; 26(8):1379-93.
    View in: PubMed
    Score: 0.024
  23. The vitamin D3 transcriptomic response in skin cells derived from the Atlantic bottlenose dolphin. Dev Comp Immunol. 2009 Aug; 33(8):901-12.
    View in: PubMed
    Score: 0.024
  24. Motoneuronotrophic factor analog GM6 reduces infarct volume and behavioral deficits following transient ischemia in the mouse. Brain Res. 2008 Oct 31; 1238:143-53.
    View in: PubMed
    Score: 0.023
  25. The dual role of tumor necrosis factor-alpha in the pathophysiology of spinal cord injury. Neurosci Lett. 2008 Jun 20; 438(2):174-9.
    View in: PubMed
    Score: 0.023
  26. Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease. Am J Pathol. 2008 May; 172(5):1342-54.
    View in: PubMed
    Score: 0.022
  27. Cysteine protease inhibitors reduce brain beta-amyloid and beta-secretase activity in vivo and are potential Alzheimer's disease therapeutics. Biol Chem. 2007 Sep; 388(9):979-83.
    View in: PubMed
    Score: 0.021
  28. Neprilysin protects neurons against Abeta peptide toxicity. Brain Res. 2007 Jun 04; 1152:191-200.
    View in: PubMed
    Score: 0.021
  29. Time window of fibroblast growth factor-18-mediated neuroprotection after occlusion of the middle cerebral artery in rats. J Cereb Blood Flow Metab. 2004 Jan; 24(1):114-23.
    View in: PubMed
    Score: 0.017
  30. Fibroblast growth factor-18 reduced infarct volumes and behavioral deficits after transient occlusion of the middle cerebral artery in rats. Stroke. 2003 Jun; 34(6):1507-12.
    View in: PubMed
    Score: 0.016
  31. Inflammation-dependent cerebral deposition of serum amyloid a protein in a mouse model of amyloidosis. J Neurosci. 2002 Jul 15; 22(14):5900-9.
    View in: PubMed
    Score: 0.015
  32. Cathepsin B Gene Knockout Improves Behavioral Deficits and Reduces Pathology in Models of Neurologic Disorders. Pharmacol Rev. 2022 07; 74(3):600-629.
    View in: PubMed
    Score: 0.015
  33. Control of ?-Site Amyloid Precursor Protein-Cleaving Enzyme-1 Expression by Protein Kinase C-?/? and Nuclear Factor ?-B. Curr Alzheimer Res. 2021; 18(12):941-955.
    View in: PubMed
    Score: 0.013
  34. Expression of mouse apolipoprotein SAA1.1 in CE/J mice: isoform-specific effects on amyloidogenesis. Lab Invest. 2000 Dec; 80(12):1797-806.
    View in: PubMed
    Score: 0.013
  35. Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice. Cytokine. 2000 Sep; 12(9):1337-47.
    View in: PubMed
    Score: 0.013
  36. Exogenous Ketone Supplements Improved Motor Performance in Preclinical Rodent Models. Nutrients. 2020 Aug 15; 12(8).
    View in: PubMed
    Score: 0.013
  37. Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat Med. 2000 Jun; 6(6):643-51.
    View in: PubMed
    Score: 0.013
  38. Expression of mouse acute-phase (SAA1.1) and constitutive (SAA4) serum amyloid A isotypes: influence on lipoprotein profiles. Arterioscler Thromb Vasc Biol. 2000 Jun; 20(6):1543-50.
    View in: PubMed
    Score: 0.013
  39. Amyloid formation in the rat: adenoviral expression of mouse serum amyloid A proteins. Amyloid. 2000 Mar; 7(1):32-40.
    View in: PubMed
    Score: 0.013
  40. Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: involvement of perturbed calcium homeostasis. J Neurosci. 2000 Feb 15; 20(4):1358-64.
    View in: PubMed
    Score: 0.013
  41. Oxidized high-density lipoprotein induces neuron death. Exp Neurol. 2000 Feb; 161(2):621-30.
    View in: PubMed
    Score: 0.013
  42. Cyclic-AMP induces Nogo-A receptor NgR1 internalization and inhibits Nogo-A-mediated collapse of growth cone. Biochem Biophys Res Commun. 2020 03 12; 523(3):678-684.
    View in: PubMed
    Score: 0.013
  43. Exogenous Ketones Lower Blood Glucose Level in Rested and Exercised Rodent Models. Nutrients. 2019 Oct 01; 11(10).
    View in: PubMed
    Score: 0.012
  44. Oxidized lipoproteins increase reactive oxygen species formation in microglia and astrocyte cell lines. Brain Res. 1999 May 29; 830(1):10-5.
    View in: PubMed
    Score: 0.012
  45. Study on the therapeutic index and synergistic effect of Chitosan-zinc oxide nanomicellar composites for drug-resistant bacterial biofilm inhibition. Int J Pharm. 2019 Jun 30; 565:472-480.
    View in: PubMed
    Score: 0.012
  46. Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements. J Vis Exp. 2019 01 07; (143).
    View in: PubMed
    Score: 0.012
  47. Delaying latency to hyperbaric oxygen-induced CNS oxygen toxicity seizures by combinations of exogenous ketone supplements. Physiol Rep. 2019 01; 7(1):e13961.
    View in: PubMed
    Score: 0.012
  48. A mouse model for serum amyloid A amyloidosis. Methods Enzymol. 1999; 309:701-16.
    View in: PubMed
    Score: 0.012
  49. Effect of nicotine use and withdrawal on brain preproenkephalin A mRNA. Brain Res. 1998 Jul 20; 799(2):257-63.
    View in: PubMed
    Score: 0.011
  50. Adenoviral expression of murine serum amyloid A proteins to study amyloid fibrillogenesis. Biochem J. 1998 Jun 15; 332 ( Pt 3):721-8.
    View in: PubMed
    Score: 0.011
  51. Reduction in amyloid A amyloid formation in apolipoprotein-E-deficient mice. Am J Pathol. 1998 May; 152(5):1387-95.
    View in: PubMed
    Score: 0.011
  52. Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms. Prog Neurobiol. 2018 Jun - Aug; 165-167:26-50.
    View in: PubMed
    Score: 0.011
  53. RhoA knockdown by cationic amphiphilic copolymer/siRhoA polyplexes enhances axonal regeneration in rat spinal cord injury model. Biomaterials. 2017 03; 121:155-166.
    View in: PubMed
    Score: 0.010
  54. The Fli-1 transcription factor is a critical regulator for controlling the expression of chemokine C-X-C motif ligand 2 (CXCL2). Mol Immunol. 2017 01; 81:59-66.
    View in: PubMed
    Score: 0.010
  55. Structure of the mouse Saa4 gene and its linkage to the serum amyloid A gene family. Genomics. 1996 May 15; 34(1):139-42.
    View in: PubMed
    Score: 0.010
  56. Non-genomic oestrogen receptor signal in B lymphocytes: An approach towards therapeutic interventions for infection, autoimmunity and cancer. Int J Biochem Cell Biol. 2016 07; 76:115-8.
    View in: PubMed
    Score: 0.010
  57. Modulation of post-stroke degenerative and regenerative processes and subacute protection by site-targeted inhibition of the alternative pathway of complement. J Neuroinflammation. 2015 Dec 30; 12:247.
    View in: PubMed
    Score: 0.009
  58. SIRT3 Deacetylates Ceramide Synthases: IMPLICATIONS FOR MITOCHONDRIAL DYSFUNCTION AND BRAIN INJURY. J Biol Chem. 2016 Jan 22; 291(4):1957-1973.
    View in: PubMed
    Score: 0.009
  59. Proteomic analysis of cerebrospinal fluid in California sea lions (Zalophus californianus) with domoic acid toxicosis identifies proteins associated with neurodegeneration. Proteomics. 2015 Dec; 15(23-24):4051-63.
    View in: PubMed
    Score: 0.009
  60. Association of apolipoprotein E with murine amyloid A protein amyloid. Lab Invest. 1995 Oct; 73(4):469-75.
    View in: PubMed
    Score: 0.009
  61. Blockade of ornithine decarboxylase enzyme protects against ischemic brain damage. J Cereb Blood Flow Metab. 1994 Nov; 14(6):1040-5.
    View in: PubMed
    Score: 0.009
  62. Prolonging life in chick forebrain-neuron culture and acquiring spontaneous spiking activity on a microelectrode array. Biotechnol Lett. 2015 Mar; 37(3):499-509.
    View in: PubMed
    Score: 0.009
  63. Single-neuron axonal pathfinding under geometric guidance: low-dose-methylmercury developmental neurotoxicity test. Lab Chip. 2014 Sep 21; 14(18):3564-71.
    View in: PubMed
    Score: 0.009
  64. Essential roles of neutral ceramidase and sphingosine in mitochondrial dysfunction due to traumatic brain injury. J Biol Chem. 2014 May 09; 289(19):13142-54.
    View in: PubMed
    Score: 0.008
  65. Brain pyroglutamate amyloid-? is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeutic. J Alzheimers Dis. 2014; 41(1):129-49.
    View in: PubMed
    Score: 0.008
  66. Structural prerequisites for serum amyloid A fibril formation. J Biol Chem. 1993 Sep 25; 268(27):20606-12.
    View in: PubMed
    Score: 0.008
  67. Inhibition of tyrosine phosphorylation prevents delayed neuronal death following cerebral ischemia. J Cereb Blood Flow Metab. 1993 May; 13(3):372-7.
    View in: PubMed
    Score: 0.008
  68. Biomaterial-based interventions for neuronal regeneration and functional recovery in rodent model of spinal cord injury: a systematic review. J Spinal Cord Med. 2013 May; 36(3):174-90.
    View in: PubMed
    Score: 0.008
  69. Tyrosine phosphorylation of microtubule-associated protein kinase after transient ischemia in the gerbil brain. J Neurochem. 1992 Nov; 59(5):1955-8.
    View in: PubMed
    Score: 0.008
  70. Role of calcium in inactivation of calcium/calmodulin dependent protein kinase II after cerebral ischemia. J Neurol Sci. 1992 Nov; 113(1):31-7.
    View in: PubMed
    Score: 0.008
  71. The alternative complement pathway propagates inflammation and injury in murine ischemic stroke. J Immunol. 2012 Nov 01; 189(9):4640-7.
    View in: PubMed
    Score: 0.008
  72. Calcium/calmodulin dependent protein kinase II mRNA in the gerbil brain after cerebral ischemia. Neurosci Lett. 1992 Sep 14; 144(1-2):75-8.
    View in: PubMed
    Score: 0.008
  73. Expression of mRNAs for PPT, CGRP, NF-200, and MAP-2 in cocultures of dissociated DRG neurons and skeletal muscle cells in administration of NGF or NT-3. Folia Histochem Cytobiol. 2012 Jul 05; 50(2):312-8.
    View in: PubMed
    Score: 0.007
  74. Cell proliferation and protooncogene induction in oligodendroglial progenitors. J Neurosci Res. 1992 Jul; 32(3):340-9.
    View in: PubMed
    Score: 0.007
  75. Transient ischemia stimulates glial fibrillary acid protein and vimentin gene expression in the gerbil neocortex, striatum and hippocampus. Brain Res Mol Brain Res. 1992 Apr; 13(3):199-206.
    View in: PubMed
    Score: 0.007
  76. Hyperglycemia suppresses c-fos mRNA expression following transient cerebral ischemia in gerbils. J Cereb Blood Flow Metab. 1992 Jan; 12(1):169-72.
    View in: PubMed
    Score: 0.007
  77. Pathogenic natural antibodies propagate cerebral injury following ischemic stroke in mice. J Immunol. 2012 Feb 01; 188(3):1460-8.
    View in: PubMed
    Score: 0.007
  78. Modulation of ornithine decarboxylase mRNA following transient ischemia in the gerbil brain. J Cereb Blood Flow Metab. 1991 Nov; 11(6):979-85.
    View in: PubMed
    Score: 0.007
  79. Cysteine Cathepsins in the secretory vesicle produce active peptides: Cathepsin L generates peptide neurotransmitters and cathepsin B produces beta-amyloid of Alzheimer's disease. Biochim Biophys Acta. 2012 Jan; 1824(1):89-104.
    View in: PubMed
    Score: 0.007
  80. Selective effects of behaviorally active doses of methamphetamine on mRNA expression in the gerbil brain. Neuropharmacology. 1991 Sep; 30(9):1011-9.
    View in: PubMed
    Score: 0.007
  81. Regulation of expression of the growth-state-related genes 2F1 and 2A9 during entry of quiescent smooth muscle cells into the cell cycle. J Cell Biochem. 1991 Aug; 46(4):345-50.
    View in: PubMed
    Score: 0.007
  82. Age-related differential expression of neuropeptide mRNAs in Aplysia. Neuroreport. 1991 Aug; 2(8):465-8.
    View in: PubMed
    Score: 0.007
  83. Targets for AD treatment: conflicting messages from ?-secretase inhibitors. J Neurochem. 2011 May; 117(3):359-74.
    View in: PubMed
    Score: 0.007
  84. Developmentally regulated ceramide synthase 6 increases mitochondrial Ca2+ loading capacity and promotes apoptosis. J Biol Chem. 2011 Feb 11; 286(6):4644-58.
    View in: PubMed
    Score: 0.007
  85. The alternative and terminal pathways of complement mediate post-traumatic spinal cord inflammation and injury. Am J Pathol. 2010 Dec; 177(6):3061-70.
    View in: PubMed
    Score: 0.007
  86. Effective post-insult neuroprotection by a novel Ca(2+)/ calmodulin-dependent protein kinase II (CaMKII) inhibitor. J Biol Chem. 2010 Jul 02; 285(27):20675-82.
    View in: PubMed
    Score: 0.006
  87. A new target for amyloid beta toxicity validated by standard and high-throughput electrophysiology. PLoS One. 2010 Jan 08; 5(1):e8643.
    View in: PubMed
    Score: 0.006
  88. Developmental expression of the Xenopus laevis fos protooncogene. Cell Growth Differ. 1990 Jan; 1(1):27-37.
    View in: PubMed
    Score: 0.006
  89. Inducible ornithine decarboxylase expression in brain subject to vasogenic oedema after transient ischaemia: relationship to C-fos gene expression. Acta Neurochir Suppl (Wien). 1990; 51:189-91.
    View in: PubMed
    Score: 0.006
  90. Genetic cathepsin B deficiency reduces beta-amyloid in transgenic mice expressing human wild-type amyloid precursor protein. Biochem Biophys Res Commun. 2009 Aug 21; 386(2):284-8.
    View in: PubMed
    Score: 0.006
  91. GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism. Proc Natl Acad Sci U S A. 2009 Jan 27; 106(4):1285-90.
    View in: PubMed
    Score: 0.006
  92. Semi-allogeneic vaccines and tumor-induced immune tolerance. J Transl Med. 2009 Jan 08; 7:3.
    View in: PubMed
    Score: 0.006
  93. Focal cerebral ischemia in the TNFalpha-transgenic rat. J Neuroinflammation. 2008 Oct 23; 5:47.
    View in: PubMed
    Score: 0.006
  94. Regeneration and characterization of adult mouse hippocampal neurons in a defined in vitro system. J Neurosci Methods. 2009 Feb 15; 177(1):51-9.
    View in: PubMed
    Score: 0.006
  95. Serum deprivation of vascular smooth muscle cells enhances collagen gene expression. J Biol Chem. 1988 Aug 15; 263(23):11426-30.
    View in: PubMed
    Score: 0.006
  96. Integrin-associated Lyn kinase promotes cell survival by suppressing acid sphingomyelinase activity. J Biol Chem. 2008 Oct 24; 283(43):28806-16.
    View in: PubMed
    Score: 0.006
  97. High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice. J Neurochem. 2008 Jul; 106(1):475-85.
    View in: PubMed
    Score: 0.006
  98. Delta 2-specific opioid receptor agonist and hibernating woodchuck plasma fraction provide ischemic neuroprotection. Acad Emerg Med. 2008 Mar; 15(3):250-7.
    View in: PubMed
    Score: 0.006
  99. Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein. J Biol Chem. 2008 Mar 21; 283(12):7745-53.
    View in: PubMed
    Score: 0.005
  100. Semi-allogeneic vaccine for T-cell lymphoma. J Transl Med. 2007 Aug 08; 5:39.
    View in: PubMed
    Score: 0.005
  101. Independent regulation of transcription of the two strands of the c-myc gene. Mol Cell Biol. 1987 Aug; 7(8):2857-62.
    View in: PubMed
    Score: 0.005
  102. JNK3 signaling pathway activates ceramide synthase leading to mitochondrial dysfunction. J Biol Chem. 2007 Aug 31; 282(35):25940-9.
    View in: PubMed
    Score: 0.005
  103. Estradiol enhances neurogenesis following ischemic stroke through estrogen receptors alpha and beta. J Comp Neurol. 2007 Feb 20; 500(6):1064-75.
    View in: PubMed
    Score: 0.005
  104. Cysteine protease inhibitors effectively reduce in vivo levels of brain beta-amyloid related to Alzheimer's disease. Biol Chem. 2007 Feb; 388(2):247-52.
    View in: PubMed
    Score: 0.005
  105. Complement-dependent P-selectin expression and injury following ischemic stroke. J Immunol. 2006 Nov 15; 177(10):7266-74.
    View in: PubMed
    Score: 0.005
  106. Regulation of oncogene expression in cultured aortic smooth muscle cells. Post-transcriptional control of c-myc mRNA. J Biol Chem. 1986 Sep 25; 261(27):12865-8.
    View in: PubMed
    Score: 0.005
  107. A dolphin peripheral blood leukocyte cDNA microarray for studies of immune function and stress reactions. Dev Comp Immunol. 2007; 31(5):520-9.
    View in: PubMed
    Score: 0.005
  108. Differential modulation of estrogen receptors (ERs) in ischemic brain injury: a role for ERalpha in estradiol-mediated protection against delayed cell death. Endocrinology. 2006 Jun; 147(6):3076-84.
    View in: PubMed
    Score: 0.005
  109. Establishment of epidermal cell lines derived from the skin of the Atlantic bottlenose dolphin (Tursiops truncatus). Anat Rec A Discov Mol Cell Evol Biol. 2005 Dec; 287(2):1246-55.
    View in: PubMed
    Score: 0.005
  110. Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene. Hum Mol Genet. 2005 Feb 01; 14(3):447-60.
    View in: PubMed
    Score: 0.004
  111. RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice. EMBO J. 2004 Oct 13; 23(20):4096-105.
    View in: PubMed
    Score: 0.004
  112. Activation of nuclear factor kappaB In vivo selectively protects the murine small intestine against ionizing radiation-induced damage. Cancer Res. 2004 Sep 01; 64(17):6240-6.
    View in: PubMed
    Score: 0.004
  113. Cholesterol and Alzheimer's disease: clinical and experimental models suggest interactions of different genetic, dietary and environmental risk factors. Curr Drug Targets. 2004 Aug; 5(6):517-28.
    View in: PubMed
    Score: 0.004
  114. Neprilysin regulates amyloid Beta peptide levels. J Mol Neurosci. 2004; 22(1-2):5-11.
    View in: PubMed
    Score: 0.004
  115. In vitro and in vivo modulations of benzo[c]phenanthrene-DNA adducts by DNA mismatch repair system. Nucleic Acids Res. 2003 Nov 15; 31(22):6428-34.
    View in: PubMed
    Score: 0.004
  116. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med. 2003 Jul; 9(7):907-13.
    View in: PubMed
    Score: 0.004
  117. Regional alterations in amyloid precursor protein and nerve growth factor across age in a mouse model of Down's syndrome. Neurosci Res. 2003 Apr; 45(4):437-45.
    View in: PubMed
    Score: 0.004
  118. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J Neurosci. 2003 Mar 15; 23(6):1992-6.
    View in: PubMed
    Score: 0.004
  119. Overexpression of SR-BI by adenoviral vector promotes clearance of apoA-I, but not apoB, in human apoB transgenic mice. J Lipid Res. 2002 Sep; 43(9):1421-8.
    View in: PubMed
    Score: 0.004
  120. Abeta deposition is essential to AD neuropathology. J Alzheimers Dis. 2002 Jun; 4(3):133-8.
    View in: PubMed
    Score: 0.004
  121. Apolipoprotein E modulates Alzheimer's Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner. Brain Res. 2002 Jan 04; 924(1):90-7.
    View in: PubMed
    Score: 0.004
  122. Key signaling pathways regulate the biological activities and accumulation of amyloid-beta. Neurobiol Aging. 2001 Nov-Dec; 22(6):967-73.
    View in: PubMed
    Score: 0.004
  123. Vulnerability of synaptosomes from apoE knock-out mice to structural and oxidative modifications induced by A beta(1-40): implications for Alzheimer's disease. Biochemistry. 2001 Feb 27; 40(8):2548-54.
    View in: PubMed
    Score: 0.003
  124. Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci U S A. 2001 Feb 13; 98(4):1952-7.
    View in: PubMed
    Score: 0.003
  125. Amyloid beta-peptide effects on synaptosomes from apolipoprotein E-deficient mice. J Neurochem. 2000 Apr; 74(4):1579-86.
    View in: PubMed
    Score: 0.003
  126. ALS-linked Cu/Zn-SOD mutation impairs cerebral synaptic glucose and glutamate transport and exacerbates ischemic brain injury. J Cereb Blood Flow Metab. 2000 Mar; 20(3):463-8.
    View in: PubMed
    Score: 0.003
  127. Lack of the p50 subunit of nuclear factor-kappaB increases the vulnerability of hippocampal neurons to excitotoxic injury. J Neurosci. 1999 Oct 15; 19(20):8856-65.
    View in: PubMed
    Score: 0.003
  128. Arachidonic acid and leukotriene C4: role in transient cerebral ischemia of gerbils. Neurochem Res. 1999 Oct; 24(10):1225-32.
    View in: PubMed
    Score: 0.003
  129. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J Cereb Blood Flow Metab. 1998 Dec; 18(12):1283-7.
    View in: PubMed
    Score: 0.003
  130. In vitro amyloid fibril formation by synthetic peptides corresponding to the amino terminus of apoSAA isoforms from amyloid-susceptible and amyloid-resistant mice. J Struct Biol. 1998 Dec 01; 124(1):88-98.
    View in: PubMed
    Score: 0.003
  131. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J Neurosci. 1998 Jan 15; 18(2):687-97.
    View in: PubMed
    Score: 0.003
  132. Adenoviral vector-mediated overexpression of serum amyloid A in apoA-I-deficient mice. J Lipid Res. 1997 Aug; 38(8):1583-90.
    View in: PubMed
    Score: 0.003
  133. Beneficial effects of S-adenosyl-L-methionine on blood-brain barrier breakdown and neuronal survival after transient cerebral ischemia in gerbils. Brain Res Mol Brain Res. 1997 Feb; 44(1):134-8.
    View in: PubMed
    Score: 0.003
  134. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med. 1996 Jul; 2(7):788-94.
    View in: PubMed
    Score: 0.002
  135. Induction of PGH synthase and c-fos mRNA during early reperfusion of ischemic rat brain. Brain Res Mol Brain Res. 1996 Jan; 35(1-2):339-43.
    View in: PubMed
    Score: 0.002
  136. Ontogeny and effect of activity on proenkephalin mRNA expression during development of the chick spinal cord. J Comp Neurol. 1994 Sep 01; 347(1):36-46.
    View in: PubMed
    Score: 0.002
  137. Serum amyloid A protein family. Differential induction by oxidized lipids in mouse strains. Arterioscler Thromb. 1994 Sep; 14(9):1475-9.
    View in: PubMed
    Score: 0.002
  138. Mouse serum amyloid A protein (SAA5) structure and expression. J Biol Chem. 1994 Feb 11; 269(6):4661-7.
    View in: PubMed
    Score: 0.002
  139. Ontogeny of proenkephalin mRNA and enkephalin peptide expression in the cerebellar cortex of the rat: spatial and temporal patterns of expression follow maturational gradients in the external granular layer and in Purkinje cells. Brain Res Dev Brain Res. 1993 Nov 19; 76(1):1-12.
    View in: PubMed
    Score: 0.002
  140. Role of protein synthesis, prostaglandins, and estrogen in rat ovarian metalloproteinase inhibitor production. Biol Reprod. 1993 May; 48(5):1006-13.
    View in: PubMed
    Score: 0.002
  141. Dose-dependent effects of aluminum on osteocalcin synthesis in osteoblast-like ROS 17/2 cells in culture. Am J Physiol. 1992 12; 263(6):E1113-8.
    View in: PubMed
    Score: 0.002
  142. Expression of the c-myb proto-oncogene in bovine vascular smooth muscle cells. J Biol Chem. 1992 Mar 05; 267(7):4625-30.
    View in: PubMed
    Score: 0.002
  143. Expression of proenkephalin mRNA in developing cerebellar cortex of the rat: expression levels coincide with maturational gradients in Purkinje cells. Brain Res Dev Brain Res. 1991 Nov 19; 63(1-2):63-9.
    View in: PubMed
    Score: 0.002
  144. Induction of the protooncogene c-fos and recovery of cytosolic adenosine triphosphate in reperfused liver after transient warm ischemia: effect of nitrone free-radical spin-trap agents. Surgery. 1991 Aug; 110(2):184-91.
    View in: PubMed
    Score: 0.002
  145. Hormonal regulation of matrix metalloproteinase inhibitors in rat granulosa cells and ovaries. Endocrinology. 1991 Apr; 128(4):1825-32.
    View in: PubMed
    Score: 0.002
  146. Ischemic induction of protooncogene expression in gerbil brain. J Mol Neurosci. 1991; 2(4):217-28.
    View in: PubMed
    Score: 0.002
  147. Heparin prevents vascular smooth muscle cell progression through the G1 phase of the cell cycle. J Biol Chem. 1989 Apr 25; 264(12):6990-5.
    View in: PubMed
    Score: 0.001
  148. Isolation of a new member of the S100 protein family: amino acid sequence, tissue, and subcellular distribution. J Cell Biol. 1989 Feb; 108(2):569-78.
    View in: PubMed
    Score: 0.001
  149. Regulation of c-myc transcription and mRNA abundance by serum growth factors and cell contact. J Biol Chem. 1986 Jul 15; 261(20):9161-6.
    View in: PubMed
    Score: 0.001
  150. Complex regulation of collagen gene expression in cultured bovine aortic smooth muscle cells. J Biol Chem. 1986 May 15; 261(14):6542-7.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.